Caricamento...
Advances in delivery systems for doxorubicin
Doxorubicin is a widely used chemotherapy agent. Despite its utility, several adverse side effects, especially its irreversible cardiotoxicity and reversible nephrotoxicity, have prompted the development of liposomal carriers, many of which are FDA approved. Antitumor efficacies of approved liposome...
Salvato in:
| Pubblicato in: | J Nanomed Nanotechnol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6319900/ https://ncbi.nlm.nih.gov/pubmed/30613436 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4172/2157-7439.1000519 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|